Skip to main content

Nanologica

Nanologica AB is a Swedish materials technology company specialized in nanoporous silica for chromatography and drug delivery applications. The company develops, manufactures, and markets silica-based media used in preparative chromatography for purifying peptide therapeutics, including insulin and GLP-1 analogues, alongside developing inhalation-based drug delivery platforms. Main revenue drivers include commercial sales of NANOAprep chromatography media and contract development fees. Nanologica serves pharmaceutical manufacturers, biopharmaceutical companies, and life science research laboratories across Europe, Asia, and North America. The company holds a specialized niche position in high-preparative silica chromatography media for peptide purification. Headquartered in Södertälje, Sweden, Nanologica AB is listed on the Nasdaq Main Market.

2 of the funds FundTelligence covers report a position in Nanologica.

Legal name
Nanologica AB
Sector
Health Care
Country
Sweden
Funds holding it
2

Funds holding Nanologica

Loading...